FIG. 4.
Effect of dose on CLR and nonrenal clearance (CLnr) of cyclic HPMPC after intravenous administration to HIV-infected patients; data are compared to baseline creatinine clearance (CLcr) data for the same patients.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.